Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2005300148 (hide)

Owner AstraZeneca AB

Inventors Henriksson, Krister; Lepisto, Matti; Hulikal, Vijaykumar; Bladh, Hakan

Agent Freehills

Pub. Number AU-A-2005300148

PCT Pub. Number WO2006/046914

Priority 0402635-7 29.10.04 SE

Filing date 26 October 2005

Wipo publication date 4 May 2006

International Classifications

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/42 (2006.01) - Oxazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4436 (2006.01)

A61K 31/4439 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 213/42 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/046914 Priority application(s): WO2006/046914

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300150-Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases

2005300145-Telephone number stamps